PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9922982-4	1998	MX1-pretreatment dose-dependently decreased the mean ulcer number and length in all doses used in an extent similar to that of roxatidine and more pronounced in comparison with bismuth subcitrate.	Bismuth	177-184	MX dynamin like GTPase 1	Rattus norvegicus	0-3	
9379358-0	1997	Gastroprotective effect of MX1 (a novel salt of the active metabolite of roxatidine with a complex of bismuth and citric acid) against stress ulcers in rats.	Bismuth	102-109	MX dynamin like GTPase 1	Rattus norvegicus	27-30	
9379358-1	1997	We have studied the effect of the newly synthesized agent MX1, a salt of the active metabolite of the H2-blocker roxatidine with a complex of bismuth and citric acid (N-[3-(3-(1-piperidinylmethyl)phenoxy)propyl]-hydroxyacetamide+ ++ -2-hydroxypropane-1,2,3-tricarboxilate-bismuth(3+) complex), against restraint stress ulcers in rats (24 h immobilization).	Bismuth	142-149	MX dynamin like GTPase 1	Rattus norvegicus	58-61	
8737057-1	1996	MX1 (N-[3-(3-(1-piperidinylmethyl)phenoxy)propyl]-hydroxyacetamide+ ++ 2-hydroxypropane-1,2,3-tricarboxylate bismuth (3+) complex) is a novel salt of the active metabolite of H2-antagonist roxatidine with a complex of bismuth with citric acid.	Bismuth	109-116	MX dynamin like GTPase 1	Rattus norvegicus	0-3	
8737057-5	1996	Microbiological tests with the reference bismuth preparation De-Nol showed prominent anti-Helicobacter properties of MX1 in-vitro.	Bismuth	41-48	MX dynamin like GTPase 1	Rattus norvegicus	117-120